Becton, Dickinson and Co. | BDX - Operating Expenses


Becton, Dickinson and Co. reported $24.42B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Agilent USD 1.43B 2M Jun/2026
Align Technology USD 864.87M 2.84M Jun/2026
AngioDynamics USD 81.95M 1.68M Sep/2025
Baxter International USD 2.68B 3.36B Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Boston Scientific USD 4.2B 49M Jun/2026
Cooper Companies USD 844.2M 268.3M Jun/2026
Danaher USD 53.62B 1.04B Sep/2026
Dentsply International USD 1.35B 33M Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Globus Medical USD 835.58M 239.73M Jun/2026
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Solventum Corp USD 4.8B 169M Jun/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 268.35M 3.7M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Terumo JPY 222.33B 46.54B Jun/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026